DekaBank Deutsche Girozentrale’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,073
Closed -$239K 1416
2022
Q2
$239K Hold
4,073
﹤0.01% 1157
2022
Q1
$340K Buy
4,073
+373
+10% +$31.1K ﹤0.01% 1128
2021
Q4
$786K Buy
3,700
+100
+3% +$21.2K ﹤0.01% 993
2021
Q3
$975K Hold
3,600
﹤0.01% 906
2021
Q2
$933K Hold
3,600
﹤0.01% 926
2021
Q1
$1.05M Hold
3,600
﹤0.01% 891
2020
Q4
$985K Sell
3,600
-180
-5% -$49.3K ﹤0.01% 872
2020
Q3
$941K Buy
+3,780
New +$941K ﹤0.01% 770
2019
Q4
Sell
-5,867
Closed -$1.59M 1189
2019
Q3
$1.59M Sell
5,867
-4,954
-46% -$1.34M 0.01% 579
2019
Q2
$5.66M Buy
10,821
+4,425
+69% +$2.31M 0.03% 401
2019
Q1
$6.39M Buy
6,396
+656
+11% +$655K 0.04% 381
2018
Q4
$2.88M Sell
5,740
-656
-10% -$330K 0.02% 472
2018
Q3
$6.39M Sell
6,396
-198
-3% -$198K 0.04% 385
2018
Q2
$4.8M Buy
6,594
+2,407
+57% +$1.75M 0.03% 406
2018
Q1
$6.6M Buy
4,187
+560
+15% +$882K 0.05% 349
2017
Q4
$1.06M Hold
3,627
0.01% 679
2017
Q3
$1.06M Hold
3,627
0.01% 688
2017
Q2
$1.05M Hold
3,627
0.01% 680
2017
Q1
$1.27M Buy
3,627
+2,227
+159% +$777K 0.01% 572
2016
Q4
$256K Buy
1,400
+107
+8% +$19.6K ﹤0.01% 792
2016
Q3
$329K Hold
1,293
﹤0.01% 749
2016
Q2
$271K Sell
1,293
-2,534
-66% -$531K ﹤0.01% 805
2016
Q1
$779K Sell
3,827
-660
-15% -$134K 0.01% 588
2015
Q4
$1.16M Buy
4,487
+74
+2% +$19K 0.01% 547
2015
Q3
$726K Buy
4,413
+153
+4% +$25.2K 0.01% 606
2015
Q2
$799K Buy
4,260
+153
+4% +$28.7K 0.01% 607
2015
Q1
$678K Sell
4,107
-440
-10% -$72.6K 0.01% 645
2014
Q4
$1.05M Sell
4,547
-420
-8% -$96.8K 0.01% 554
2014
Q3
$899K Buy
4,967
+127
+3% +$23K 0.01% 533
2014
Q2
$931K Buy
4,840
+167
+4% +$32.1K 0.01% 509
2014
Q1
$850K Buy
4,673
+273
+6% +$49.7K 0.01% 498
2013
Q4
$764K Buy
4,400
+100
+2% +$17.4K 0.01% 482
2013
Q3
$674K Buy
+4,300
New +$674K 0.01% 507